These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17897055)

  • 21. Autoimmune diseases: MIF as a therapeutic target.
    Greven D; Leng L; Bucala R
    Expert Opin Ther Targets; 2010 Mar; 14(3):253-64. PubMed ID: 20148714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.
    Bloom J; Metz C; Nalawade S; Casabar J; Cheng KF; He M; Sherry B; Coleman T; Forsthuber T; Al-Abed Y
    J Biol Chem; 2016 Dec; 291(51):26502-26514. PubMed ID: 27793992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of the role of macrophage migration inhibitory factor (MIF) in inflammatory bowel disease.
    Nishihira J; Mitsuyama K
    Curr Pharm Des; 2009; 15(18):2104-9. PubMed ID: 19519441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.
    Ayoub S; Hickey MJ; Morand EF
    Nat Clin Pract Rheumatol; 2008 Feb; 4(2):98-105. PubMed ID: 18235539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery.
    Lolis E
    Curr Opin Pharmacol; 2001 Dec; 1(6):662-8. PubMed ID: 11757824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock.
    Calandra T; Bucala R
    J Inflamm; 1995-1996; 47(1-2):39-51. PubMed ID: 8913928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development.
    Bloom J; Sun S; Al-Abed Y
    Expert Opin Ther Targets; 2016 Dec; 20(12):1463-1475. PubMed ID: 27762152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization, epitope identification and mechanisms of the anti-septic capacity of monoclonal antibodies against macrophage migration inhibitory factor.
    Zhang Y; Zeng X; Chen S; Zhang Z; Li P; Yi W; Huang H; Yao J; Li S; Hu C
    Int Immunopharmacol; 2011 Sep; 11(9):1333-40. PubMed ID: 21571101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage migration inhibitory factor.
    Baugh JA; Bucala R
    Crit Care Med; 2002 Jan; 30(1 Suppl):S27-35. PubMed ID: 11782558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system.
    Calandra T; Bucala R
    Crit Rev Immunol; 1997; 17(1):77-88. PubMed ID: 9034724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4).
    Roger T; Froidevaux C; Martin C; Calandra T
    J Endotoxin Res; 2003; 9(2):119-23. PubMed ID: 12803886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
    Sinitski D; Kontos C; Krammer C; Asare Y; Kapurniotu A; Bernhagen J
    Thromb Haemost; 2019 Apr; 119(4):553-566. PubMed ID: 30716779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine properties of macrophage migration inhibitory factor (MIF).
    Fingerle-Rowson GR; Bucala R
    Immunol Cell Biol; 2001 Aug; 79(4):368-75. PubMed ID: 11488984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders.
    Kok T; Wasiel AA; Cool RH; Melgert BN; Poelarends GJ; Dekker FJ
    Drug Discov Today; 2018 Nov; 23(11):1910-1918. PubMed ID: 29936245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine monoclonal antibodies directed against human recombinant Macrophage Migration Inhibitory Factor.
    Rupreht RR; Moyetic B; Franckz A; Matis M; Skoberne M; Galvani V; Malovrh T; Kotnik V; Curin Serbec V
    Pflugers Arch; 2000; 440(5 Suppl):R78-80. PubMed ID: 11005620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth.
    Nishihira J
    J Interferon Cytokine Res; 2000 Sep; 20(9):751-62. PubMed ID: 11032394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage migration inhibitory factor as a target molecule in multiple sclerosis.
    Nishihira J; Ogata A
    Curr Opin Investig Drugs; 2001 Jun; 2(6):778-82. PubMed ID: 11572656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases.
    Renner P; Roger T; Calandra T
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S513-9. PubMed ID: 16237655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
    Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
    Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
    Nicoletti F; Créange A; Orlikowski D; Bolgert F; Mangano K; Metz C; Di Marco R; Al Abed Y
    J Neuroimmunol; 2005 Nov; 168(1-2):168-74. PubMed ID: 16171874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.